Login / Signup

Clinical estimation of α/β values for prostate cancer from isoeffective phase III randomized trials with moderately hypofractionated radiotherapy.

Niloy Ranjan DattaEmanuel StutzSusanne RogersStephan Bodis
Published in: Acta oncologica (Stockholm, Sweden) (2018)
Clinically estimated α/β for PCa from isoeffective randomized trials using known variables in the linear-quadratic expression ranged between 1.3 and 11.1 Gy. The estimated α/β values were inversely related to %ADT usage, which should be considered when planning future RT dose-fractionation schedules.
Keyphrases